<span item_type="fundamental" item_id="a73de74d9eeff36052315568fbb49544" counter_id="ST/US/LFMDP" env="prod"></span><span item_type="announcement" item_id="583885228193027713" env="prod"></span><p>Revenue: As of FY2025 Q3, the actual value is USD 60.17 M.</p><p>EPS: As of FY2025 Q3, the actual value is USD -0.1.</p><p>EBIT: As of FY2025 Q3, the actual value is USD -1.707 M.</p><p></p><h3>Segment Revenue</h3><ul><li>Total revenue increased 13% year-over-year to $60.2 million, driven by an 18% increase in telehealth revenue to $47.3 million.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/ex99-1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>Gross margin was 88%, down from 91% in the prior-year period, due to revenue mix. Telehealth gross margin, excluding WorkSimpli, was 86% compared to 89% in the year-ago period.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/ex99-1.htm"></span></li><li>GAAP net loss was $4.6 million or - $0.10 per share, compared to a net loss of $5.4 million or - $0.13 per share in the prior-year period.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/ex99-1.htm"></span></li><li>Adjusted EBITDA increased 20% to $5.1 million, with telehealth adjusted EBITDA rising 30% to $2.9 million.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/ex99-1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>Cash totaled $23.8 million as of September 30, 2025, following the payoff of approximately $17 million of all remaining debt in the third quarter.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/ex99-1.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>The number of active telehealth subscribers increased 14% to approximately 310,000 at quarter-end.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/ex99-1.htm"></span></li></ul><h3>Outlook / Guidance</h3><ul><li>For the fourth quarter of 2025, LifeMD expects revenue in the range of $45 million to $46 million and adjusted EBITDA between $3 million and $4 million.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/ex99-1.htm"></span></li><li>For the full year 2025, the company anticipates revenue between $192 million and $193 million, reflecting a 24% increase versus 2024, and adjusted EBITDA between $13.5 million and $14.5 million, reflecting a 254% increase versus 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/948320/000149315225023853/ex99-1.htm"></span></li></ul>

LifeMD Pref Share LFMDP 8.875 Perp 10/15/22 | 8-K: FY2025 Q3 Revenue: USD 60.17 M